• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

David Pariser, MD, FACP, FAAD, Joins Vial Dermatology CRO


Vial announced another addition to their CRO with David Pariser, MD, FACP, FAAD.

The Vial Dermatology contract research organization (CRO)added David Pariser, MD, FACP, FAAD, senior physician at Pariser Dermatology Specialists, Norfolk, Virginia, to the Vial Scientific Advisory Board. He will share his knowledge and insights from his 40-plus years as a practicing dermatologist to the Vial CRO team and dermatology sponsors. This comes a few weeks after it was announced that Vial added Mark Lebwohl, MD, a Dermatology Times® editorial board member and dean of clinical therapeutics at the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York, New York.

The Vial CRO was launched earlier this year and taglined as “The CRO Built for Sponsors”. The new organization is powered by the Vial Clinical Network which is comprised of more than 35 dermatology clinics throughout the United States.

The scientific advisory board’s KOLs will service sponsors in clinical strategy, regulatory strategy, trial design, and overall clinical development plan pathways. Betsey Zbyszynski leads the Vial CRO team as the head of clinical operations. The team includes Jason Shuris as head of sales; Janet DuBois, MD, a dermatologist and principal researcher at DermResearch in Austin, Texas, as medical director; Justin Withers as head of dermatology; and Mamta Hunt as head of quality. The Vial CRO executive team have a combined 100-plus years of dermatology clinical trial experience.

“I am excited to support the Vial team, along with their sponsors, as they utilize technology to advance the field of dermatology research,” Pariser said.

Pariser is board-certified by the American Board of Dermatology and the American Board of Pathology with a special competence in Dermatopathology. He is known forhis expertise on psoriasis, hyperhidrosis, and photodynamic therapy. Throughout the span of his career, his research has led to the publication of over 300 scientific publications and 4 textbooks in medical literature, according to the release.

In 2009, Pariser was elected as the president of the American Academy of Dermatology (AAD) and was awarded the gold medal of the AAD in 2017. In addition, he was honored with the title “Educator of the Year” by the Fall and Winter Clinical Dermatology Conferences. Pariser is also a member of the Executive Committee of the International League of Dermatologic Societies, the world body of dermatology. In this position, he has traveled to Tanzania on several occasions to provide patient care and dermatology education to seriously under-served populations in sub-Saharan Africa.


Dr. David Pariser joins Vial’s scientific advisory board. Cision PR Newswire. Press release. Published March 10, 2022. Accessed March 10, 2022. https://www.prnewswire.com/news-releases/dr-david-pariser-joins-vials-scientific-advisory-board-301499897.html

Related Videos
© 2024 MJH Life Sciences

All rights reserved.